Search Results 231-240 of 17011 for Incidence

  1. Neurology - Clinical trials - Mayo Clinic

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  2. A Study of the Effect of Myectomy on the Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy - Mayo Clinic

    ... incidence of sudden cardiac death. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  3. Hussam Tabaja, M.D. - Mayo Clinic Faculty Profiles

    Infections associated with vascular grafts. Dr. Tabaja has published research findings about the incidence of vascular graft-related infections and the ...

  4. Ureteral injury malpractice compensation highest in cases of patient-perceived delays, inadequate workup and failure of supervision - Mayo Clinic

    The overall incidence of significant ureteral injury in gynecologic and colorectal surgeries has been estimated to be as high as 1.7% and 1.9%, respectively.

  5. Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia - Mayo Clinic

    Incidence of graft versus host disease (GVHD), as well as incidence of acute GVHD and chronic GVHD within 6 months and 2 years. Engraftment at 6 months, 1 ...

  6. Lidocaine and epinephrine (injection route) - Mayo Clinic

    Incidence not known. Bluish-colored lips, fingernails, or palms blurred or double vision; chest pain or discomfort; cold, clammy, pale skin; confusion ...

  7. Docetaxel (intravenous route) - Mayo Clinic

    Incidence not known. Hearing loss; pain and redness of the skin at the place of earlier radiation treatment. Other side effects not listed may ...

  8. Ethinyl estradiol and ethynodiol diacetate (oral route) - Mayo Clinic

    Incidence not known. Absent, missed, or irregular menstrual periods; anxiety; bloody stools; blurred vision; breast tenderness, enlargement, discharge; changes ...

  9. Ferric derisomaltose (intravenous route) - Mayo Clinic

    Incidence not known. Chest pain; fast, pounding, or irregular heartbeat or pulse; fever or chills; headache; loss of consciousness; nervousness; pounding in the ...

  10. A Study to Determine if Sugammadex and Quantitative Monitoring Postoperatively Will Reduce Residual Weakness - Mayo Clinic

    We hypothesize that the incidence of postoperative residual weakness with sugammadex and quantitative monitoring is low (<5%) and that patients receiving ...